BioComp Providing Refunds for 340B Overcharges Spanning a Whopping 8 Years

BioComp Pharma product list
Following a HRSA audit, BioComp Pharma is offering 340B covered entities refunds on six products for overcharges spanning eight years.

Generic-drug manufacturer BioComp is offering covered entities refunds for lower 340B prices that it did not pay on six NDCs for periods over eight years, starting in Q3 2013 and ending in Q2 2021.

BioComp, a wholly-owned subsidiary of San

Read More »

Feds Take Over Prosecution of Whistleblower Suit Against Tenn. Health System Alleged to Have Paid Cancer Docs Illegally for Referrals that Boosted 340B Profits

Methodist University hospital building
The federal government has decided to intervene in a 340B-related whistleblower lawsuit involving Methodist University Hospital in Memphis, Tenn.

The federal government has decided to intervene in a whistleblower lawsuit that accuses a Tennessee health system of paying Memphis-area cancer physicians for referrals that allegedly generated about $70 million a year in profits for the health system from billings

Read More »

California 340B Health Centers Say State “Essentially Admits” Flaws in Medicaid Drug Reimbursement Change

Sherman Heights Family Health Center building
California health centers want a federal court to stop a state Medicaid policy that deprives them of millions of dollars in 340B drug reimbursement.

California health centers told a federal judge last week that the state’s arguments for dismissing the centers’ lawsuit to reverse a new state Medicaid policy that deprives them of millions of dollars in 340B drug reimbursement lack merit.

Community Health

Read More »

News Alert

HRSA Starts Contacting Hospitals Forced Out of 340B During Pandemic About Possible Reinstatement

Dept. of Health and Human Services exterior sign and building
HRSA began contacting hospitals today about possible reinstatement in 340B if their termination was due to their DSH adjustment percentage falling as a result of the hospital's COVID-19 response.

UPDATE Friday, March 18, 2022, 1:30 p.m. EDT—The U.S. Health Resources and Services Administration (HRSA) told 340B Report shortly after this story was published, “To be eligible, [a] hospital’s termination must have been as a result of actions taken by

Read More »

For 2-3 Years, CMS Could Pay 340B Hospitals More for Pricey New Alzheimer’s Drug Than Current Norm

A box and bottle of prescription drug Aduhelm
MedPAC says that for two or three years CMS likely would pay 340B hospitals more for the expensive new Alzheimer's drug Aduhelm than it normally would for a Part B drug.

Medicare likely would pay 340B hospitals 106% of the average sales price (ASP) for Aduhelm—Biogen’s high-cost biologic drug for early-stage Alzheimer’s disease—for the first two or three years it is on the market, not the ASP minus 22.5% 340B hospital

Read More »

CMS Asks Judge to Dismiss 340B Health Centers’ Claims in Suit Over Medicaid Drug Benefits Transfer

A California benefits identification card
CMS told a judge last week it "has no authority to second-guess California’s decision" to transfer Medicaid managed care drug benefits to Medicaid fee for service.

The U.S. Centers for Medicare & Medicaid Services (CMS) asked a federal district judge in Sacramento last week to dismiss California health centers’ claims for relief over CMS’s approval of the state’s transfer of Medicaid managed care drug benefits to

Read More »

Judge Clears Way for Feds to Appeal His Ruling in AstraZeneca’s 340B Contract Pharmacy Lawsuit

AstraZeneca building-mounted sign
A federal judge has cleared the way for the federal government to appeal his decision in AstraZeneca's 340B contract pharmacy lawsuit.

A federal district judge on Friday entered his final orders and judgement in AstraZeneca’s 340B contract pharmacy lawsuit, clearing the way for the government to file its anticipated appeal.

Judge Leonard Stark of the District of Delaware closed the first

Read More »

Biden to Sign Bill Today Giving Some Relief to Hospitals Forced Out of 340B Due to COVID-19

President Biden signing legislation in the Oval Office
President Biden is due to sign legislation this afternoon that will help some hospitals forced out of the 340B program during the COVID-19 pandemic.

President Biden is scheduled this afternoon to sign a $1.5 trillion federal appropriations bill with language to help some hospitals forced out of the 340B program during the COVID-19 pandemic.

The bill also gives the U.S. Health Resources and Services

Read More »

News Alert

U.S. Senate OK’s Limited Relief for Hospitals Forced Out of 340B Due to COVID-19

U.S Senate chamber seen from public gallery
The U.S. Senate gave final passage last night to legislation to help some hospitals forced out of the 340B program during the COVID-19 pandemic.

The U.S. Senate last night passed a $1.5 trillion federal appropriations bill with language to help some hospitals forced out of the 340B program during the COVID-19 pandemic.

The House passed the bill Wednesday night. President Biden is expected

Read More »

U.S. House Approves Partial Relief for Hospitals Forced Out of 340B Due to COVID-19

U.S. House chamber in session
The U.S. House last night passed a spending bill with language to aid hospitals forced out of 340B due to patient mix changes caused by the COVID-19 pandemic.

The U.S. House last night passed a $1.5 trillion omnibus appropriations bill with language to help hospitals whose admission patterns have been so disrupted by COVID-19 that their Medicare disproportionate share (DSH) adjustment percentages have fallen below the levels needed

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report